Locus-aware transcriptome-wide Mendelian randomization prioritizes candidate loci and expression traits for chronic kidney disease
This study employs a locus-aware transcriptome-wide Mendelian randomization framework to identify 28 chronic kidney disease-associated expression traits across nine candidate loci, prioritizing ANKUB1 and RSAD2 as distinct non-MHC candidates with strong colocalization support while highlighting the unresolved complexity of the MHC region.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Chronic kidney disease is a silent, progressive condition that affects millions of people worldwide, often leading to premature death or the need for dialysis. While doctors can slow its progression, a significant risk remains even with treatment, largely because scientists do not fully understand which specific genes drive the disease. To find these genetic culprits, researchers often look at how our DNA influences the production of proteins, a process known as gene expression. However, the human genome is a crowded neighborhood where genes sit close together and share regulatory switches. This makes it difficult to tell if a genetic signal points to one specific gene or if it is simply a reflection of a whole cluster of genes acting in unison. Distinguishing between a single causal gene and a group of correlated neighbors is the central challenge in translating genetic data into biological understanding.
A team of researchers from Shanxi Medical University and Shanxi Bethune Hospital in China has tackled this problem by applying a new, more careful way of looking at genetic data for chronic kidney disease. Instead of treating every gene that showed a statistical link to the disease as a separate discovery, they grouped these genes into "loci," or physical neighborhoods on the chromosome, to see if the signals were independent or just different faces of the same underlying genetic variation. Using data from over 14,000 patients with chronic kidney disease and nearly 480,000 healthy controls, they analyzed nearly 15,300 different gene expression traits. Their goal was to filter out the noise of correlated signals and identify the most promising candidates for future study.
The analysis began by testing each gene expression trait to see if it was associated with the disease. The researchers found 28 traits that showed a statistically significant link. At first glance, this might look like 28 different genes causing the disease. However, when the team mapped these findings onto the genome, a different picture emerged. Nineteen of these 28 traits were clustered tightly together in a single, complex region of the immune system known as the major histocompatibility complex. This area is notorious for having genes that are so closely linked and regulated together that it is nearly impossible to tell which one is the primary driver of a disease signal. The researchers concluded that these 19 findings likely represent a single, complex genetic signal rather than 19 independent causes.
After accounting for this crowded region, the study narrowed its focus to nine distinct candidate locations across the genome. Among these, two genes stood out as the most promising non-immune candidates: ANKUB1 and RSAD2. Both genes showed strong evidence that their genetic regulation and the disease risk were driven by the same underlying genetic variant. ANKUB1 was particularly notable because its link to the disease was statistically robust and showed nominal evidence of association when checked against an independent dataset of patients, although it did not survive a strict correction for multiple testing in that second group. RSAD2 also showed a strong connection, but its link was slightly less certain in the independent check. The researchers prioritized these two genes not because they knew exactly how they caused the disease, but because the genetic evidence was the most consistent and least likely to be a statistical fluke.
The study also revisited a gene called IER3, which sits within that complex immune region. While IER3 showed a very strong statistical link to the disease, the researchers could not definitively say it was the sole cause because it is surrounded by so many other genes that move in lockstep. The evidence suggested that IER3 is part of the problem, but the current data cannot isolate it from its neighbors. Furthermore, when the researchers looked at how these genes behaved in actual kidney tissue samples, the results were mixed. Some showed patterns that matched the genetic predictions, while others showed the opposite, suggesting that the disease process is influenced by many factors, including tissue damage and the body's response to injury, rather than a single straightforward mechanism.
The researchers were careful to state that their work does not prove these genes are the definitive causes of chronic kidney disease, nor does it immediately point to a new drug target. Instead, the study serves as a map that clears away the clutter of correlated signals to highlight the most likely areas for future investigation. By grouping the findings into nine operational locations rather than listing 28 separate genes, the team provided a clearer, more honest picture of the genetic landscape. They identified ANKUB1 and RSAD2 as the top candidates for functional follow-up, while acknowledging that the complex immune region remains a puzzle that requires more advanced tools to solve. This approach ensures that future experiments are not wasted on genes that are merely bystanders to the real genetic drivers, offering a more efficient path toward understanding the biology of kidney failure.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.